相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Wolfgang P. Fendler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma
Christos Sachpekidis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
Is 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
Robert Seifert et al.
JOURNAL OF NUCLEAR MEDICINE (2023)
Gene's expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study
Matteo Bauckneht et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research Applications
Aadil Adnan et al.
DIAGNOSTICS (2023)
Combined [68 Ga]Ga-PSMA-11 and low-dose 2-[18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy
Ian Alberts et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
Radiotheranostics in oncology: Making precision medicine possible
Eric O. Aboagye et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
A systematic review for using deep learning in bone scan classification
Yung-Shuo Kao et al.
CLINICAL AND TRANSLATIONAL IMAGING (2023)
Detection efficacy of analog [18F]FDG PET/CT, digital [18F]FDG, and [13N]NH3 PET/CT: a prospective, comparative study of patients with lung adenocarcinoma featuring ground glass nodules
Zhifeng Chen et al.
EUROPEAN RADIOLOGY (2023)
Molecular imaging in oncology: Current impact and future directions
Steven P. Rowe et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review
Samuele Ghezzo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer
Ruohua Chen et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives
Luca Urso et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Lutetium Lu 177 Vipivotide Tetraxetan: First Approval
Susan J. Keam
MOLECULAR DIAGNOSIS & THERAPY (2022)
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature
Pierpaolo Alongi et al.
CANCERS (2022)
The ImSURE phantoms: a digital dataset for radiomic software benchmarking and investigation
Andrea Bettinelli et al.
SCIENTIFIC DATA (2022)
PSMA Expression in Solid Tumors beyond the Prostate Gland: Ready for Theranostic Applications?
Chiara Lauri et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA
Majid Assadi et al.
FRONTIERS IN ONCOLOGY (2022)
Radiotheranostics in oncology: current challenges and emerging opportunities
Lisa Bodei et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Baseline Imaging Derived Predictive Factors of Response Following [Lu-177]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis
Esmee C. A. van der Sar et al.
BIOMEDICINES (2022)
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review
Luca Urso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, 2 trial
James P. Buteau et al.
LANCET ONCOLOGY (2022)
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
Alessio Rizzo et al.
CANCERS (2022)
Bone Health Management in the Continuum of Prostate Cancer Disease
Ettickan Boopathi et al.
CANCERS (2022)
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial
Luca Urso et al.
PHARMACEUTICS (2022)
Theragnostic Radionuclide Pairs for Prostate Cancer Management: 64Cu/67Cu, Can Be a Budding Hot Duo
Anupriya Chhabra et al.
BIOMEDICINES (2022)
[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature
Laura Evangelista et al.
EUROPEAN UROLOGY ONCOLOGY (2022)
Digital PET/CT with 18F-FACBC in early castration-resistant prostate cancer: our preliminary results
Luca Filippi et al.
EXPERT REVIEW OF MEDICAL DEVICES (2022)
ImmunoPET for prostate cancer in the PSMA era: do we need other targets?
Luca Filippi et al.
CLINICAL AND TRANSLATIONAL IMAGING (2022)
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
Luca Urso et al.
CLINICAL AND TRANSLATIONAL IMAGING (2022)
Radiomics in prostate cancer: an up-to-date review
Matteo Ferro et al.
THERAPEUTIC ADVANCES IN UROLOGY (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol
Frederic Pouliot et al.
BJU INTERNATIONAL (2021)
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Kerstin Michalski et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA
Benedikt Feuerecker et al.
EUROPEAN UROLOGY (2021)
18F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastases
Kalevi Kairemo et al.
CURRENT PROBLEMS IN CANCER (2021)
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Michael S. Hofman et al.
LANCET (2021)
Additional Value of PET Radiomic Features for the Initial Staging of Prostate Cancer: A Systematic Review from the Literature
Priscilla Guglielmo et al.
CANCERS (2021)
Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies
Jake Kendrick et al.
FRONTIERS IN ONCOLOGY (2021)
Decision-support for treatment with 177Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET/CT and clinical parameters
Sobhan Moazemi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer
Nicholas Mitsiades et al.
ENDOCRINE-RELATED CANCER (2021)
Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging
Hannes Gruenig et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy
Sandy Srinivas et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
PSMA Theranostics: Current Landscape and Future Outlook
Hanbo Zhang et al.
CANCERS (2021)
Evaluation of 68Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving 177Lu-PSMA-617 Therapy: A Radiomics Analysis
Wolfgang Roll et al.
CANCERS (2021)
90Y/177Lu-DOTATOC: From Preclinical Studies to Application in Humans
Licia Uccelli et al.
PHARMACEUTICS (2021)
Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon
Yoshitaka Toyama et al.
THERANOSTICS (2021)
Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
Madhav Prasad Yadav et al.
CLINICAL NUCLEAR MEDICINE (2020)
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223
Matteo Bauckneht et al.
CANCERS (2020)
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients
Giovanni Paganelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
PET/CT Radiomics in Lung Cancer: An Overview
Francesco Bianconi et al.
APPLIED SCIENCES-BASEL (2020)
Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
Andrea Cimini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer
Luca Filippi et al.
EXPERT REVIEW OF MEDICAL DEVICES (2020)
Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer
Wen-Ting K. Tsai et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
The potential of PSMA-targeted alpha therapy in the management of prostate cancer
Luca Filippi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Prognostic Value of 18F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
Luca Filippi et al.
BIOMEDICINES (2020)
Results of a Prospective Phase 2 Pilot Trial of 177Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression
Louise Emmett et al.
CLINICAL GENITOURINARY CANCER (2019)
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
Martin K. Bakht et al.
ENDOCRINE-RELATED CANCER (2019)
Radiomic Machine Learning: Is It Really a Useful Method for the Characterization of Prostate Cancer?
Michele Scialpi et al.
RADIOLOGY (2019)
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis
Mari Suominen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Imaging-Based Individualized Response Prediction Of Carbon Ion Radiotherapy For Prostate Cancer Patients
Shuang Wu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
Thorsten D. Poeppel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients
Arthur Letellier et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
Kambiz Rahbar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma
Luca Filippi et al.
FUTURE ONCOLOGY (2018)
Profiling Prostate Cancer Therapeutic Resistance
Cameron A. Wade et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies
Denise S. O'Keefe et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
Michael S. Hofman et al.
LANCET ONCOLOGY (2018)
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience
Kalevi Kairemo et al.
CURRENT RADIOPHARMACEUTICALS (2018)
Big healthcare data: preserving security and privacy
Karim Abouelmehdi et al.
JOURNAL OF BIG DATA (2018)
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE
Maddalena Sansovini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617
Justin Ferdinandus et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
Hojjat Ahmadzadehfar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
Iain Murray et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Technical Challenges in the Clinical Application of Radiomics
Faiq A. Shaikh et al.
JCO CLINICAL CANCER INFORMATICS (2017)
Theranostics of Neuroendocrine Tumors
Sze Ting Lee et al.
VISCERAL MEDICINE (2017)
Molecular response assessed by 68Ga-DOTANOC and survival after 90Y microsphere therapy in patients with liver metastases from neuroendocrine tumours
Luca Filippi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
Massimiliano Pacilio et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy
Elba C. Etchebehere et al.
CLINICAL NUCLEAR MEDICINE (2016)
Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
Christie Lin et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
Andrei H. Iagaru et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
64Cu2+ Ions as PET Probe: An Emerging Paradigm in Molecular Imaging of Cancer
Rubel Chakravarty et al.
MOLECULAR PHARMACEUTICS (2016)
VPAC1 Targeted 64Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man
Sushil Tripathi et al.
UROLOGY (2016)
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT
Kalevi Kairemo et al.
DIAGNOSTICS (2015)
Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis-A Systematic Review and Pooled Analysis
Hai Tao Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Skeletal SPECT/CT: a review
Torsten Kuwert
CLINICAL AND TRANSLATIONAL IMAGING (2014)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy
Shinji Kurosaka et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Radiomics: Extracting more information from medical images using advanced feature analysis
Philippe Lambin et al.
EUROPEAN JOURNAL OF CANCER (2012)
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
Tina Binderup et al.
CLINICAL CANCER RESEARCH (2010)
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms
Jinlu Dai et al.
CANCER RESEARCH (2008)
Skeletal PET with F-18-fluoride: Applying new technology to an old tracer
Frederick D. Grant et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
SPECT/CT with a hybrid camera: a new imaging modality for the functional anatomical mapping of infections
Luca Filippi et al.
EXPERT REVIEW OF MEDICAL DEVICES (2006)
Intraoperative gamma probe detection of head and neck paragangliomas with 111In-pentetreotide:: A pilot study
L Filippi et al.
TUMORI JOURNAL (2005)